Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DVM Life Sciences is a pharmaceutical company based in Hyderabad, India, that specializes in the development, manufacturing, and export of Active Pharmaceutical Ingredients (APIs), pharmaceutical pellets, and finished dosage forms. The company is recognized for its expertise in pelletization technology, offering a wide range of sustained-release and delayed-release products for global markets. Their therapeutic focus spans several key areas, including gastroenterology, cardiology, and antifungal treatments, with a portfolio featuring high-demand generics like Omeprazole and Itraconazole. DVM Life Sciences operates state-of-the-art facilities that adhere to Good Manufacturing Practices (GMP), ensuring high-quality standards for their international clientele. By providing cost-effective manufacturing and robust R&D support, the company serves as a vital link in the global pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DVM Life Sciences.